[go: up one dir, main page]

GT200700026A - Vehiculo de proteina de suero de leche para una entrega del agente activo - Google Patents

Vehiculo de proteina de suero de leche para una entrega del agente activo

Info

Publication number
GT200700026A
GT200700026A GT200700026A GT200700026A GT200700026A GT 200700026 A GT200700026 A GT 200700026A GT 200700026 A GT200700026 A GT 200700026A GT 200700026 A GT200700026 A GT 200700026A GT 200700026 A GT200700026 A GT 200700026A
Authority
GT
Guatemala
Prior art keywords
active agent
delivery
serum protein
milk serum
protein vehicle
Prior art date
Application number
GT200700026A
Other languages
English (en)
Inventor
Christophe Joseph Etienne Schmitt
Lionen Jean Rene Bovetto
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of GT200700026A publication Critical patent/GT200700026A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23F—COFFEE; TEA; THEIR SUBSTITUTES; MANUFACTURE, PREPARATION, OR INFUSION THEREOF
    • A23F3/00—Tea; Tea substitutes; Preparations thereof
    • A23F3/16—Tea extraction; Tea extracts; Treating tea extract; Making instant tea
    • A23F3/30—Further treatment of dried tea extract; Preparations produced thereby, e.g. instant tea
    • A23F3/32—Agglomerating, flaking or tabletting or granulating
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING OR TREATMENT THEREOF
    • A23C21/00—Whey; Whey preparations
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23F—COFFEE; TEA; THEIR SUBSTITUTES; MANUFACTURE, PREPARATION, OR INFUSION THEREOF
    • A23F5/00—Coffee; Coffee substitutes; Preparations thereof
    • A23F5/24—Extraction of coffee; Coffee extracts; Making instant coffee
    • A23F5/36—Further treatment of dried coffee extract; Preparations produced thereby, e.g. instant coffee
    • A23F5/40—Further treatment of dried coffee extract; Preparations produced thereby, e.g. instant coffee using organic additives, e.g. milk, sugar
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23J—PROTEIN COMPOSITIONS FOR FOODSTUFFS; WORKING-UP PROTEINS FOR FOODSTUFFS; PHOSPHATIDE COMPOSITIONS FOR FOODSTUFFS
    • A23J3/00—Working-up of proteins for foodstuffs
    • A23J3/04—Animal proteins
    • A23J3/08—Dairy proteins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23P—SHAPING OR WORKING OF FOODSTUFFS, NOT FULLY COVERED BY A SINGLE OTHER SUBCLASS
    • A23P10/00—Shaping or working of foodstuffs characterised by the products
    • A23P10/30—Encapsulation of particles, e.g. foodstuff additives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/0241—Containing particulates characterized by their shape and/or structure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/0241—Containing particulates characterized by their shape and/or structure
    • A61K8/0275—Containing agglomerated particulates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/0291—Micelles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/56—Compounds, absorbed onto or entrapped into a solid carrier, e.g. encapsulated perfumes, inclusion compounds, sustained release forms

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Epidemiology (AREA)
  • Birds (AREA)
  • Dermatology (AREA)
  • Biochemistry (AREA)
  • Nutrition Science (AREA)
  • Zoology (AREA)
  • Cosmetics (AREA)
  • Dairy Products (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicinal Preparation (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

LA PRESENTE INVENCIÓN SE REFIERE A UN MÉTODO PARA PREPARAR AGREGADOS DE MICELAS DE PROTEÍNA Y UN AGENTE ACTIVO, EL MÉTODO SE CARACTERIZA PORQUE COMPRENDE LAS ETAPAS DE:
GT200700026A 2006-03-27 2007-03-26 Vehiculo de proteina de suero de leche para una entrega del agente activo GT200700026A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP06006297A EP1839498B1 (en) 2006-03-27 2006-03-27 Whey protein vehicle for active agent delivery

Publications (1)

Publication Number Publication Date
GT200700026A true GT200700026A (es) 2007-11-02

Family

ID=36950192

Family Applications (1)

Application Number Title Priority Date Filing Date
GT200700026A GT200700026A (es) 2006-03-27 2007-03-26 Vehiculo de proteina de suero de leche para una entrega del agente activo

Country Status (17)

Country Link
US (1) US9198445B2 (es)
EP (1) EP1839498B1 (es)
CN (1) CN101472484B (es)
AR (1) AR060165A1 (es)
AT (1) ATE506861T1 (es)
AU (1) AU2007231347B2 (es)
BR (1) BRPI0708930A2 (es)
CL (1) CL2007000813A1 (es)
DE (1) DE602006021533D1 (es)
DK (1) DK1839498T3 (es)
ES (1) ES2365246T3 (es)
GT (1) GT200700026A (es)
MX (1) MX2008012334A (es)
PL (1) PL1839498T3 (es)
PT (1) PT1839498E (es)
WO (1) WO2007110422A2 (es)
ZA (1) ZA200809163B (es)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK1839504T3 (da) * 2006-03-27 2009-06-08 Nestec Sa In situ-fremstilling af valleprotein-miceller
ATE472317T1 (de) * 2006-03-27 2010-07-15 Nestec Sa Kosmetische verwendung von molkeproteinmizellen
CN103005464B (zh) 2008-10-17 2015-01-07 雀巢产品技术援助有限公司 乳清蛋白组合物、方法及用途
EP2229824A1 (en) * 2009-03-12 2010-09-22 Nestec S.A. Covalent milk protein/isothiocyanate complexes
EP2229823A1 (en) * 2009-03-12 2010-09-22 Nestec S.A. Electrostatic protein/glucosinolate complexes
WO2010110921A1 (en) * 2009-03-26 2010-09-30 Moobella, Inc. Frozen dessert compositions having increased overrun percentage
CA2783975C (en) * 2009-12-18 2014-06-17 Stokely-Van Camp, Inc. Protein recovery beverage
GB201101669D0 (en) 2011-01-31 2011-03-16 Ip Science Ltd Carotenoid particles and uses thereof
EP2583564A1 (en) 2011-10-21 2013-04-24 Nestec S.A. Use of whey protein micelles for improving insulin profile in diabetic patients
EP2583563A1 (en) * 2011-10-21 2013-04-24 Nestec S.A. Whey protein micelles against muscle atrophy and sarcopenia
WO2014104872A1 (en) * 2012-12-28 2014-07-03 N.V. Nutricia Method for the preparation of a liquid enteral nutritional composition comprising micellar casein
US9452146B2 (en) 2013-03-15 2016-09-27 Glanbia Nutritionals (Ireland) Ltd. Product and method for improving bioavailability of therapeutic compounds
JP2016526914A (ja) 2013-09-12 2016-09-08 インターコンチネンタル グレート ブランズ エルエルシー タンパク質を含むマトリクス中にマイクロカプセル化風味料を含む、チューインガム組成物
US11896029B2 (en) 2014-12-23 2024-02-13 Cargill, Incorporated Emulsion and process for making same
EP3389396B1 (en) * 2015-12-18 2019-11-13 Société des Produits Nestlé S.A. Hydration for animals
US12501924B2 (en) 2015-12-30 2025-12-23 Compagnie Gervais Danone Compositions comprising whey protein and Gum Arabic
EP3484304B1 (en) 2016-07-15 2020-09-02 Arla Foods Amba Method of producing concentrated or dried acid-gellable whey protein aggregates, and related compositions and food products
CN110099696A (zh) * 2016-12-23 2019-08-06 哥本哈根大学 物质和蛋白质的共无定形形式
US11197917B2 (en) 2017-12-01 2021-12-14 ByHeart, Inc. Formulations for nutritional support in subjects in need thereof
US20190343141A1 (en) * 2018-05-10 2019-11-14 Ach Food Companies, Inc. Oil and fat substitutes
CN108912345B (zh) * 2018-06-27 2020-06-09 江南大学 一种基于浓缩乳蛋白的微胶囊壁材及微胶囊
CN110786511A (zh) * 2019-11-12 2020-02-14 武汉轻工大学 一种乳清分离蛋白糖基化反应产物制备姜黄素均匀乳液的方法和姜黄素均匀乳液
IT202000011803A1 (it) * 2020-05-20 2021-11-20 Hudson River Biotechnology B V Particella multistrato incapsulante una molecola biologicamente attiva
KR102651539B1 (ko) * 2020-08-18 2024-03-29 푸드사이언스, 엘엘씨 중합된 유청 단백질 캡슐화된 항산화제 화합물 및 이를 제조하기 위한 프로세스
EP4258888A1 (en) * 2020-12-08 2023-10-18 FrieslandCampina Nederland B.V. Process for producing a nutritional product comprising whey protein and oligosaccharide
IT202000030992A1 (it) * 2020-12-16 2022-06-16 Tech Scientific S R L Sistema per il rilascio controllato di principi attivi
EP4119126A1 (en) 2021-07-13 2023-01-18 Zeroharm Sciences Private Limited Nanoformulation with diverse functional molecules from turmeric and process for preparation of the same

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL181326C (nl) 1979-11-20 1987-08-03 Stichting Bedrijven Van Het Werkwijze voor de bereiding van voedingsmiddelen waarin een in water oplosbare gedenatureerde wei-eiwitsamenstelling wordt opgenomen alsmede werkwijze ter bereiding van oplosbare gedenatureerde wei-eiwitsamenstellingen.
EP0180441B1 (en) 1984-10-30 1989-08-09 H.M.O. Nominees Pty. Ltd. Manufacture of cheese flavour powder
US5260083A (en) 1992-03-25 1993-11-09 The J. M. Smucker Company Fruit spread and method of preparing same
US5350590A (en) 1992-12-15 1994-09-27 Beatreme Foods Inc. Protein fat replacer and method of manufacture thereof
JP2683492B2 (ja) 1993-09-07 1997-11-26 雪印乳業株式会社 ミセル状ホエー蛋白質、その溶液、その粉末およびミセル状ホエー蛋白質の製造法
US5601760A (en) 1994-09-01 1997-02-11 The Regents Of The University Of California, A California Corporation Milk derived whey protein-based microencapsulating agents and a method of use
US5756136A (en) * 1995-06-02 1998-05-26 Mccormick & Company, Inc. Controlled release encapsulation compositions
US6673384B1 (en) 1998-01-30 2004-01-06 The Procter & Gamble Co. Creamy mouthfeel agent for foods and beverages
DE19964370B4 (de) 1999-02-16 2006-05-11 Huss, Manfred Herstellung eines geschäumten Molkenproteinprodukts
US6757575B1 (en) 2000-06-22 2004-06-29 Sony Corporation Systems and methods for implementing audio de-clicking
US20020051843A1 (en) 2000-07-24 2002-05-02 Baker Lois A. High-foaming, stable modified whey protein isolate
WO2002034052A2 (en) * 2000-10-24 2002-05-02 Cp Kelco U.S. Inc. Co-processed emulsifier/carrier systems for full-fat bakery products
CA2449202A1 (en) * 2001-05-23 2002-11-28 Institut National De La Recherche Scientifique Biocompatible compositions as carriers or excipients for pharmaceutical and nutraceutical formulations and for food protection
KR100502840B1 (ko) * 2002-09-04 2005-07-21 학교법인 포항공과대학교 약물 담지능력이 우수한 블록 공중합체 미셀 조성물
US6824810B2 (en) 2002-10-01 2004-11-30 The Procter & Gamble Co. Creamer compositions and methods of making and using the same
US7018668B2 (en) 2003-02-06 2006-03-28 Procter & Gamble Co. Low fat creamer compositions
ES2373937T3 (es) 2003-11-21 2012-02-10 Commonwealth Scientific And Industrial Research Organisation Sistemas gastro-intestinales de administración.
MY153295A (en) * 2004-09-29 2015-01-29 Nestec Sa Nanoparticulated whey proteins

Also Published As

Publication number Publication date
WO2007110422A3 (en) 2009-01-15
AU2007231347A1 (en) 2007-10-04
EP1839498B1 (en) 2011-04-27
CN101472484A (zh) 2009-07-01
BRPI0708930A2 (pt) 2011-06-14
WO2007110422A2 (en) 2007-10-04
EP1839498A1 (en) 2007-10-03
ZA200809163B (en) 2010-01-27
AU2007231347B2 (en) 2012-11-01
PL1839498T3 (pl) 2011-09-30
US20090162485A1 (en) 2009-06-25
CL2007000813A1 (es) 2008-01-25
MX2008012334A (es) 2008-11-28
PT1839498E (pt) 2011-07-25
CN101472484B (zh) 2016-08-03
ATE506861T1 (de) 2011-05-15
US9198445B2 (en) 2015-12-01
DK1839498T3 (da) 2011-08-01
DE602006021533D1 (de) 2011-06-09
ES2365246T3 (es) 2011-09-27
AR060165A1 (es) 2008-05-28

Similar Documents

Publication Publication Date Title
GT200700026A (es) Vehiculo de proteina de suero de leche para una entrega del agente activo
CY1122181T1 (el) Φαρμακοτεχνικη μορφη αντισωματος
AR122746A2 (es) Una formulación farmacéutica líquida estable de anticuerpo
CY1118601T1 (el) Αλκυλαμινο-υποκατεστημενες δικυανοπυριδινες και προφαρμακα τυπου εστερα αμινοξεος αυτων
PL2178504T3 (pl) Roztwór oczny na bazie prostagladyn bez środka konserwującego
CO6771428A2 (es) Composición efervescente en forma sólida para uso en aplicaciones vaginales para el tratamiento de infecciones vaginales
NI201400841A (es) Composición veterinaria blanda masticable para tratar y/o prevenir una infección o infección de parásitos en un animal
MX375417B (es) Uso de ácido (r)-2-[3-[[n-(benzoxazol-2-il)-n-3-(4-metoxifenoxi)propil]aminometil]fenoxi]butírico o una sal, o solvato del mismo para el tratamiento de la esteatosis hepática no alcohólica, supresión de la deposición de grasa en el hígado, y en la reducción de células de kupffer en el hígado.
CR20110204A (es) Moleculas de anticuerpo mejoradas
MX383895B (es) Formulacion de isoxazolina topica localizada.
EP2331072A4 (en) METHOD AND COMPOSITIONS FOR ORAL ADMINISTRATION OF PROTEINS
BR112015030514A2 (pt) Composições e métodos para conjugação de anticorpos ativáveis
AR081681A1 (es) METODOS Y COMPOSICIONES PARA LA ADMINISTRACION INTRATECAL DE b-GALACTOCEREBROSIDASA
NI201100025A (es) Métodos de administración de las formulaciones tópicas antimicóticas para el tratamiento de las infecciones por hongos.
MX382443B (es) Una formulación estable para usarse en el tratamiento de la enfermedad por leucodistrofia metacromática (mld).
AR098168A1 (es) Formulación estable de insulina glulisina
MX2013002058A (es) Composicion de tratamiento para cabello.
CL2013000097A1 (es) Composicion farmaceutica combinada que incluye una forma activada potenciada de un anticuerpo de la proteina s-100 y una forma activada potenciada de un anticuerpo anti tnf-alfa; metodos para el tratamiento de las enfermedades o condiciones funcionales del tracto gastrointestinal.
ES2429422R1 (es) Composición farmacéutica y su uso para preparar un medicamento destinado al tratamiento y la prevención de enfermedades causadas por el VIH
CO2017007316A2 (es) Formulación farmacéutica
CL2013002119A1 (es) Composicion insecticida que comprende un vehiculo degradable, un compuesto de amonio, una fuente de proteina, una fuente de azucar, uno o mas insecticidas y agua; proceso para aplicar la composicion.
EA201490862A1 (ru) Осмотически активная система вагинальной доставки
UA107346C2 (en) Use of nifuratel to treat infections caused by atopobium species
ES2440393R1 (es) Un método para aumentar el efecto de una forma activada potenciada de un anticuerpo
UY31059A1 (es) Formulaciones de aminoacido n-halogenado